{"prompt": "['APPROVED RPCI IRB', '3/22/2021', 'Roswell Park Protocol No.: I 33616', 'Normal tissue toxicity grade (Arm 2, Appendix F)', '8.5', 'ABOUT 1 WEEK POST TREATMENT', 'Clinical examination with photograph of lesion if possible', 'Vital signs (i.e., temperature, heart rate, respiratory rate, blood pressure, and body weight)', 'Correlative studies blood samples (for participants randomized to PDT only)', 'Normal tissue toxicity grade (Appendix F)', 'Adverse events', '8.6', 'ABOUT 4 - 6 WEEKS POST TREATMENT', 'Clinical examination with photograph of lesion if possible', 'Vital signs (i.e., temperature, heart rate, respiratory rate, blood pressure, and body weight)', 'Correlative studies blood samples (for participants randomized to PDT only)', 'Normal tissue toxicity grade (for participants randomized to PDT only) (Appendix F)', 'Adverse events', '8.7 ABOUT 12 - 16 WEEKS POST TREATMENT', 'Clinical examination with photograph of lesion if possible', 'Vital signs (i.e., temperature, heart rate, respiratory rate, blood pressure, and body weight)', 'Performance status (ECOG): Appendix D', 'Response, clinical (for both arms)', 'Response, pathological, biopsy for all participants.', 'Quality of Life Questionnaire: Appendix H', '8.8', 'POST-TREATMENT FOLLOW-UP EVALUATIONS', 'Post treatment follow-up evaluations will occur every 3 - 4 months in year 1, 3 - 6 months in', 'year 2, per the NCCN guidelines.', 'Clinical examination with photograph of lesion, if possible', 'Vital signs (i.e., temperature, heart rate, respiratory rate, blood pressure, and body weight)', 'Performance status (ECOG): Appendix D', 'Response, clinical (at each follow-up and at 2 years)', 'Response, pathological, biopsy, will be performed during routine visits, only if clinically', 'indicated', 'Confirm tumor staging with CT or MRI scans of the head and neck and chest, only if', 'clinically indicated', 'Quality of Life Questionnaire at 6, 12, 18, and 24 months: Appendix H.', 'PRIVATE AND CONFIDENTIAL INFORMATION OF ROSWELL PARK CANCER INSTITUTE', '01-14-21', 'Page 28 of 64']['APPROVED RPCI IRB', '3/22/2021', 'Roswell Park Protocol No.: I 33616', '8.9 SCHEDULE OF PROCEDURES AND OBSERVATIONS', 'The schedule of procedures and observations for this study is summarized in Table 2 and Table 3', 'below.', 'PRIVATE AND CONFIDENTIAL INFORMATION OF ROSWELL PARK CANCER INSTITUTE', '01-14-21', 'Page 29 of 64']['Roswell Park Protocol No.: I 33616', 'Table 2', 'Schedule of Procedures and Observations for Participants Randomized to PDT', '~1 Week', 'Day 0', 'Day 1', 'Post', '~4-6 Weeks', '~12-16 Weeks', 'Baseline\u00b9', 'Infusion', 'Treatment', 'Treatment', 'Post Treatment', 'Post Treatment', 'Follow-Up\u00b2', 'History, Physical', 'X', 'Clinical Exam (with lesion photograph', 'X', 'X', 'X', 'X', 'X', 'if possible)', 'Confirm tumor staging with CT or', 'MRI scans of the head and neck and', 'X', 'X10', 'chest', 'Vital Signs (i.e., temperature, heart', 'rate, respiratory rate, blood pressure,', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'body weight, and height\u00b3', 'Hematology5', 'X', 'Chemistry6', 'X', 'Blood Samples (if possible) for', 'correlative studies (immune,', 'X', 'X', 'X', 'photosensitizer & biomarker analyses', '7', 'Biopsy (diagnosis)', 'X', 'HCG urine or serum for women of', 'X', 'childbearing potential', 'HPPH Infusion', 'X', 'Optical spectroscopy', 'X', 'Laser', 'X', 'Normal Tissue Toxicity Grade', 'X', 'X', 'X', 'Performance Status/ECOG', 'X', 'X', 'X', 'Response, Clinical', 'X', 'X', 'X', '(Evaluate Lesion Size)', 'Response, Pathological, Biopsy', 'X', 'X8', 'Quality of Life Questions', 'X', 'X', 'X9', 'Adverse Events', 'X', 'X', 'X', 'PRIVATE AND CONFIDENTIAL INFORMATION OF ROSWELL PARK CANCER INSTITUTE', '01-14-21', 'Page 30 of 64']\n\n###\n\n", "completion": "END"}